| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-06 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | 0.18 | 1e-06 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.19 | 2e-06 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.18 | 3e-06 |
| mRNA | decitabine:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.19 | 3e-06 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | 0.17 | 3e-06 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.16 | 3e-06 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-06 |